Comparison of Myrtus Communis L. and Descurainia Sophia L. versus salicylic acid in the treatment of wart

Comparison the efficacy of Myrtus Communis L. and Descurainia Sophia L. as a method of traditional medicine versus salicylic acid in the treatment of wart

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2012092710947N1

Enrollment

100

Registered

2012-12-17

Start date

2013-06-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wart. Viral warts

Interventions

Intervention 1: 1) 1 drop of 16.5 % salicylic acid on each wart, once daily for 40 days. The base of salicylic acid is flexible collodion 4%. Primary substances are obtained from Sepidaj Pharmaceutica

Treatment - Drugs

1) 1 drop of 16.5 % salicylic acid on each wart, once daily for 40 days. The base of salicylic acid is flexible collodion 4%. Primary substances are obtained from Sepidaj Pharmaceutical co. Tehran.

2) 1 drop of 16.5 % salicylic acid on each wart, once daily for 40 days and Descurainia Sophia L. twice a day 4.5 grams (gr) with adequate boiling water till 3 months.

Salving leaves of Myrtus Communis L. that is processed by 1 x leaves of Myrtus Communis L. and 2 x water on each wart ,twice a day for 40 days

Salving leaves of Myrtus Communis L. that is processed by 1 x leaves of Myrtus Communis L. and 2 x water on each wart ,twice a day forl 40 days and Descurainia Sophia L. twice a day 4.5 gr with adequa

Eligibility

Sex/Gender

All

Age

6 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1) Patients between 6 to 45 years old 2) Patients who live in Yazd 3) Total number of wart 20 6) Warts on face 7) anogenital warts 8) Wound or active dermatologic diseases on warts 9) Receiving any treatment during prior month 10) Patients disaffiliation.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
The number of warts. Timepoint: Days 0, 20, 40 and 3 months after beginning of treatment. Method of measurement: Observation.;The size of warts. Timepoint: Days 0, 20, 40 and 3 months after beginning of treatment. Method of measurement: In millimeter by ruler.;The period of time that warts recovered after beginning of treatment. Timepoint: Days 0, 20, 40 and 3 months after beginning of treatment. Method of measurement: Day.;The relapse rate. Timepoint: Days 0, 20, 40 and 3 months after beginning of treatment. Method of measurement: Observation.	—

Measure

Time frame

The number of warts. Timepoint: Days 0, 20, 40 and 3 months after beginning of treatment. Method of measurement: Observation.;The size of warts. Timepoint: Days 0, 20, 40 and 3 months after beginning of treatment. Method of measurement: In millimeter by ruler.;The period of time that warts recovered after beginning of treatment. Timepoint: Days 0, 20, 40 and 3 months after beginning of treatment. Method of measurement: Day.;The relapse rate. Timepoint: Days 0, 20, 40 and 3 months after beginning of treatment. Method of measurement: Observation.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElham Ghadami Yazdi

School of Traditional Medicine, Tehran University of Medical Sciences

ELHAM_GHADAMI@YAHOO.COME-GHADAMIYAZDI@RAZI.TUMS.AC.IR+98 35 1724 3788

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026